I am a
Home I AM A Search Login

Papers of the Week

Papers: 26 Mar 2022 - 1 Apr 2022

2022 Mar 30

J Headache Pain



Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience.


Raffaelli B, Terhart M, Mecklenburg J, Neeb L, Overeem L H, Siebert A, Steinicke M, Reuter U
J Headache Pain. 2022 Mar 30; 23(1):40.
PMID: 35350990.


Migraine frequency increases after the cessation of successful preventive treatment with CGRP(-receptor) monoclonal antibodies (mAbs). In this study, we aimed to evaluate the course of migraine after treatment resumption.